348 related articles for article (PubMed ID: 14594546)
1. Cyclooxygenase-2 modulates cellular growth and promotes tumorigenesis.
Trifan OC; Hla T
J Cell Mol Med; 2003; 7(3):207-22. PubMed ID: 14594546
[TBL] [Abstract][Full Text] [Related]
2. Cancer research. Anti-inflammatories inhibit cancer growth--but how?
Marx J
Science; 2001 Jan; 291(5504):581-2. PubMed ID: 11233414
[No Abstract] [Full Text] [Related]
3. Cyclooxygenase-2 expression by nonsteroidal anti-inflammatory drugs in human airway smooth muscle cells: role of peroxisome proliferator-activated receptors.
Pang L; Nie M; Corbett L; Knox AJ
J Immunol; 2003 Jan; 170(2):1043-51. PubMed ID: 12517972
[TBL] [Abstract][Full Text] [Related]
4. Control of COX-2 gene expression through peroxisome proliferator-activated receptor gamma in human cervical cancer cells.
Han S; Inoue H; Flowers LC; Sidell N
Clin Cancer Res; 2003 Oct; 9(12):4627-35. PubMed ID: 14555539
[TBL] [Abstract][Full Text] [Related]
5. [Biological functions of cyclooxygenase 2: control of its expression and activity].
Jacquemin C
J Soc Biol; 2000; 194(3-4):189-93. PubMed ID: 11324321
[TBL] [Abstract][Full Text] [Related]
6. COX-2, NSAIDs and human neoplasia. Part I: Colorectal neoplasms.
Nasir A; Fernandez PM; Chughtai OR; Kaiser HE
In Vivo; 2002; 16(6):501-9. PubMed ID: 12494894
[TBL] [Abstract][Full Text] [Related]
7. Direct evidence for a role of cyclooxygenase 2-derived prostaglandin E2 in human head and neck xenograft tumors.
Zweifel BS; Davis TW; Ornberg RL; Masferrer JL
Cancer Res; 2002 Nov; 62(22):6706-11. PubMed ID: 12438270
[TBL] [Abstract][Full Text] [Related]
8. Peroxisome proliferator-activated receptor gamma (PPARgamma) ligands as bifunctional regulators of cell proliferation.
Na HK; Surh YJ
Biochem Pharmacol; 2003 Oct; 66(8):1381-91. PubMed ID: 14555212
[TBL] [Abstract][Full Text] [Related]
9. Characterization of cyclooxygenase-2 (COX-2) during tumorigenesis in human epithelial cancers: evidence for potential clinical utility of COX-2 inhibitors in epithelial cancers.
Koki AT; Khan NK; Woerner BM; Seibert K; Harmon JL; Dannenberg AJ; Soslow RA; Masferrer JL
Prostaglandins Leukot Essent Fatty Acids; 2002 Jan; 66(1):13-8. PubMed ID: 12051953
[TBL] [Abstract][Full Text] [Related]
10. Cyclooxygenase-2 inhibitors in tumorigenesis (Part II).
Taketo MM
J Natl Cancer Inst; 1998 Nov; 90(21):1609-20. PubMed ID: 9811310
[TBL] [Abstract][Full Text] [Related]
11. Nimesulide, a preferential cyclooxygenase 2 inhibitor, suppresses peroxisome proliferator-activated receptor induction of cyclooxygenase 2 gene expression in human synovial fibroblasts: evidence for receptor antagonism.
Kalajdzic T; Faour WH; He QW; Fahmi H; Martel-Pelletier J; Pelletier JP; Di Battista JA
Arthritis Rheum; 2002 Feb; 46(2):494-506. PubMed ID: 11840453
[TBL] [Abstract][Full Text] [Related]
12. Adverse renal effects of anti-inflammatory agents: evaluation of selective and nonselective cyclooxygenase inhibitors.
Gambaro G; Perazella MA
J Intern Med; 2003 Jun; 253(6):643-52. PubMed ID: 12755960
[TBL] [Abstract][Full Text] [Related]
13. Effects of NSAIDs on proliferation of gastric cancer cells in vitro: possible implication of cyclooxygenase-2 in cancer development.
Sawaoka H; Kawano S; Tsuji S; Tsujii M; Murata H; Hori M
J Clin Gastroenterol; 1998; 27 Suppl 1():S47-52. PubMed ID: 9872498
[TBL] [Abstract][Full Text] [Related]
14. Cyclooxygenase-2-derived prostaglandin D(2) is an early anti-inflammatory signal in experimental colitis.
Ajuebor MN; Singh A; Wallace JL
Am J Physiol Gastrointest Liver Physiol; 2000 Jul; 279(1):G238-44. PubMed ID: 10898767
[TBL] [Abstract][Full Text] [Related]
15. The cyclooxygenase-2 structure: new drugs for an old target?
Garavito RM
Nat Struct Biol; 1996 Nov; 3(11):897-901. PubMed ID: 8901861
[No Abstract] [Full Text] [Related]
16. Expression of cyclooxygenase-2 and peroxisome proliferator-activated receptor-gamma and levels of prostaglandin E2 and 15-deoxy-delta12,14-prostaglandin J2 in human breast cancer and metastasis.
Badawi AF; Badr MZ
Int J Cancer; 2003 Jan; 103(1):84-90. PubMed ID: 12455057
[TBL] [Abstract][Full Text] [Related]
17. Activation of peroxisome proliferator-activated receptor gamma suppresses inducible cyclooxygenase and nitric oxide synthase during oral mucosal ulcer healing.
Slomiany BL; Slomiany A
J Physiol Pharmacol; 2002 Jun; 53(2):159-69. PubMed ID: 12120893
[TBL] [Abstract][Full Text] [Related]
18. PPARgamma-mediated antineoplastic effect of NSAID sulindac on human oral squamous carcinoma cells.
Nikitakis NG; Hebert C; Lopes MA; Reynolds MA; Sauk JJ
Int J Cancer; 2002 Apr; 98(6):817-23. PubMed ID: 11948457
[TBL] [Abstract][Full Text] [Related]
19. [The role of cyclooxygenase and prostaglandins in the pathogenesis of rheumatoid arthritis].
Stańczyk J; Kowalski ML
Pol Merkur Lekarski; 2001 Nov; 11(65):438-43. PubMed ID: 11852819
[TBL] [Abstract][Full Text] [Related]
20. Prostaglandin biology.
Crofford LJ
Gastroenterol Clin North Am; 2001 Dec; 30(4):863-76. PubMed ID: 11764532
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
